115 related articles for article (PubMed ID: 8769215)
21. Change of conventional cyclosporine to neoral cyclosporine formulation in long-term liver transplant recipients.
Diliz HS; Olivera MA; Kershenobich D; Mercado MA; Orozco H
Transplant Proc; 1996 Dec; 28(6):3348-50. PubMed ID: 8962302
[No Abstract] [Full Text] [Related]
22. Microemulsion cyclosporine (Neoral) immunosuppression for orthotopic liver transplantation in children reduces hospital stay.
Arumugam R; Soriano HE; Scheimann AO; Reid BS; Gopalakrishna GS; Barakat O; Ozaki CF; Wood RP
Transplant Proc; 1998 Aug; 30(5):1848-9. PubMed ID: 9723304
[No Abstract] [Full Text] [Related]
23. Increased dosage requirement and rejection after Neoral conversion in pediatric liver transplant patients.
Cao S; Cox KL; Berquist W; So S; Concepcion W; Monge H; Esquivel CO
Transplant Proc; 1998 Dec; 30(8):4322-4. PubMed ID: 9865373
[No Abstract] [Full Text] [Related]
24. Case study: conversion of a liver transplant patient from cyclosporine Sandimmune to Neoral.
Levy GA
Transplant Proc; 1996 Aug; 28(4):2252-3. PubMed ID: 8769216
[No Abstract] [Full Text] [Related]
25. Microemulsion cyclosporine with C2 monitoring and tacrolimus in liver transplantation with or without hepatitis C virus infection.
Jain A
Liver Transpl; 2006 Oct; 12(10):1452-4. PubMed ID: 17004248
[No Abstract] [Full Text] [Related]
26. Tacrolimus (FK506) is superior to cyclosporine in liver transplantation.
Busuttil RW; Holt CD
Transplant Proc; 1997; 29(1-2):534-8. PubMed ID: 9123119
[No Abstract] [Full Text] [Related]
27. The TMC study.
Davies MH; Millson CE; Breslin NP
Lancet; 2003 Jan; 361(9354):346; author reply 347. PubMed ID: 12559886
[No Abstract] [Full Text] [Related]
28. 12-month follow-up analysis of a multicenter, randomized, prospective trial in de novo liver transplant recipients (LIS2T) comparing cyclosporine microemulsion (C2 monitoring) and tacrolimus.
Levy G; Grazi GL; Sanjuan F; Wu Y; Mühlbacher F; Samuel D; Friman S; Jones R; Cantisani G; Villamil F; Cillo U; Clavien PA; Klintmalm G; Otto G; Pollard S; McCormick PA
Liver Transpl; 2006 Oct; 12(10):1464-72. PubMed ID: 17004259
[TBL] [Abstract][Full Text] [Related]
29. Cyclosporine peak levels provide a better correlation with the area-under-the-curve than trough levels in liver transplant patients treated with neoral.
Cantarovich M; Barkun J; Besner JG; Metrakos P; Alpert E; Deschénes M; Aalamian Z; Tchervenkov JI
Transplant Proc; 1998 Jun; 30(4):1462-3. PubMed ID: 9636593
[No Abstract] [Full Text] [Related]
30. Neoral-based immunosuppression in living-related donor liver transplantation.
Liu PP; Chen CL; Chen YS; Wang CC; Chiang YC; Goto S; Cheng YF; Huang TL; Eng HL; Cheung HK; Jawan B
Transplant Proc; 1998 Nov; 30(7):3550-1. PubMed ID: 9838554
[No Abstract] [Full Text] [Related]
31. [Comparison between tacrolimus (FK 506) and cyclosporin in immunosuppressive therapy after liver transplantation].
Arnold JC; Theilmann L
Z Gastroenterol; 1995 Oct; 33(10):624-5. PubMed ID: 7502559
[No Abstract] [Full Text] [Related]
32. Comparison of the long-term tolerability, pharmacodynamics, and safety of Sandimmune and Neoral in liver transplant recipients. Ontario Liver Transplant Study Group.
Grant D; Rochon J; Levy G
Transplant Proc; 1996 Aug; 28(4):2232-3. PubMed ID: 8769208
[No Abstract] [Full Text] [Related]
33. Safety and tolerability of Neoral in transplant recipients.
Feutren G; Wong R; Jin J; Niese D; Mellein B
Transplant Proc; 1996 Aug; 28(4):2177-82. PubMed ID: 8769193
[No Abstract] [Full Text] [Related]
34. Conversion from Sandimmune to Neoral in stable liver graft recipients.
Pollard SG; Lodge JP
Transplant Proc; 1996 Aug; 28(4):2244-6. PubMed ID: 8769213
[No Abstract] [Full Text] [Related]
35. Neoral in liver transplantation.
Jamieson NV; Tan L; Jamieson I; Trull A; Gimson AE; Alexander G; Friend PJ; Calne RY
Transplant Proc; 1996 Aug; 28(4):2229-31. PubMed ID: 8769207
[No Abstract] [Full Text] [Related]
36. Absorption of cyclosporine Neoral early after liver transplantation: influence of bile on oral absorption.
Oldhafer K; Haller GW; Kattner A; Winkler M; Maibücher A; Färber L; Bechstein WO; Ringe B; Neuhaus P; Pichlmayr R
Transplant Proc; 1996 Aug; 28(4):2237-8. PubMed ID: 8769210
[No Abstract] [Full Text] [Related]
37. [Tacrolimus and hypertrophic cardiomyopathy].
Romero E; Hevia S; Castellanos D; Simarro C
Med Clin (Barc); 1998 Jun; 110(20):804-5. PubMed ID: 9666425
[No Abstract] [Full Text] [Related]
38. Uses of Neoral in pediatric liver transplantation.
McDiarmid SV
Transplant Proc; 1996 Aug; 28(4):2264-6. PubMed ID: 8769220
[No Abstract] [Full Text] [Related]
39. Absorption of cyclosporine Neoral early after liver transplantation: is it possible to abandon intravenous cyclosporine A application?
Haller GW; Winkler M; Bechstein WO; Oldhafer KJ; Ringe B; Maibücher A; Färber L; Pichlmayr R; Neuhaus P
Transplant Proc; 1996 Aug; 28(4):2239-40. PubMed ID: 8769211
[No Abstract] [Full Text] [Related]
40. Administration of tacrolimus in 50 liver transplantation patients.
Ye QF; Ruzig MA; Gong NQ
Hepatobiliary Pancreat Dis Int; 2002 Nov; 1(4):492-4. PubMed ID: 14607673
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
